Skandinaviska Enskilda Banken AB publ Sells 19,758 Shares of Cigna Group $CI

Skandinaviska Enskilda Banken AB publ trimmed its holdings in shares of Cigna Group (NYSE:CIFree Report) by 8.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 208,558 shares of the health services provider’s stock after selling 19,758 shares during the period. Skandinaviska Enskilda Banken AB publ owned approximately 0.08% of Cigna Group worth $60,117,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the business. Solstein Capital LLC purchased a new stake in shares of Cigna Group during the second quarter valued at $29,000. Harbor Capital Advisors Inc. lifted its stake in Cigna Group by 119.5% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock valued at $26,000 after acquiring an additional 49 shares during the period. Chilton Capital Management LLC bought a new position in Cigna Group during the 2nd quarter valued at about $30,000. Princeton Global Asset Management LLC boosted its holdings in shares of Cigna Group by 115.6% during the 2nd quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after acquiring an additional 52 shares during the last quarter. Finally, Quaker Wealth Management LLC grew its stake in shares of Cigna Group by 201.0% in the second quarter. Quaker Wealth Management LLC now owns 106 shares of the health services provider’s stock worth $35,000 after acquiring an additional 211 shares during the period. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE CI opened at $291.35 on Tuesday. The business’s fifty day moving average is $277.40 and its 200 day moving average is $283.75. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74. The company has a market capitalization of $77.83 billion, a PE ratio of 13.14, a price-to-earnings-growth ratio of 1.01 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the company earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. Sell-side analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date is Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. Cigna Group’s payout ratio is 27.23%.

Analyst Ratings Changes

A number of brokerages recently weighed in on CI. Wall Street Zen upgraded shares of Cigna Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Guggenheim restated a “buy” rating and issued a $318.00 price target on shares of Cigna Group in a research note on Monday, February 2nd. JPMorgan Chase & Co. cut their price objective on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a report on Tuesday, November 4th. Royal Bank Of Canada reduced their price objective on Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a research report on Friday, February 6th. Finally, Sanford C. Bernstein reissued a “market perform” rating and issued a $307.00 target price on shares of Cigna Group in a research report on Tuesday, January 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $330.00.

Check Out Our Latest Report on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Articles

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.